Sterigenics International LLC, a provider of contract sterilization, gamma technologies and medical isotopes, is expanding its Fort Worth location with the addition of a new gamma cell that will increase capacity by 30 percent, the . Deerfield, Illinois company announced Jan. 5L Expansion will be complete by the second quarter of 2017, according to a press release from the company.
“We have committed more than $80 million in capital investments in the past year to support our customers’ growth strategies,” said Michael Mulhern, CEO of Sterigenics International in a news release. “In addition to our Fort Worth expansion, we tripled sterilization capacity at the Sterigenics West Memphis, Arkansas location; significantly expanded our Gurnee, Illinois irradiation facility and increased our global service capabilities with the acquisition of leading Latin American sterilization firm Companhia Brasileira de Esterilização (CBE).”
“The Fort Worth expansion is the direct result of increased regional demand for Sterigenics irradiation services,” said Philip Macnabb, president of Sterigenics Internationa. “We are adding gamma processing capacity of up to 5 million cubic feet per year in Texas, with a product overlap system which will provide the capability to process numerous dose ranges and a wide variety of densities.”
Opened in 1984, Sterigenics Fort Worth provides routine gamma, GammaStat rapid processing, process validation and SteriPro laboratory testing. Operating out of 47 facilities in 12 countries across the Americas, Europe and Asia, Sterigenics provides contract sterilization and ionization services for the medical device, pharmaceutical, food safety, and high-performance materials industries. The company is owned by private equity firms Warburg Pincus and GTCR. Its Fort Worth location is at 3125 Wichita Court, 76028.